Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy

The office building of biopharmaceutical company AstraZeneca is being seen in Shanghai, China, on May 23, 2024. A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest healthcare news straight to your inbox. Subscribe here to receive future editions. AstraZeneca said it is doubling down on its investment in its U.S. business, a move that comes just one week after Donald Trump's election win. AstraZeneca announced plans for $2 billion in new spending on research ...